Published: 2020-03-25 14:50 | Updated: 2022-03-25 13:42

First collaboration between partners in the NextGenNK competence center

Avectas and Vycellix Announce Collaboration to Advance Next-Generation Solutions for the Optimized Manufacture of Cell & Gene Therapies. NextGenNK catalyzed interaction among its industrial partners to advance NK cell-based immunotherapies